JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krayer, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krayer, O.
Journal of Pharmacology And Experimental Therapeutics, Vol. 100, Issue 2, 146-150, 1950
Copyright © 1950 by American Society for Pharmacology and Experimental Therapeutics


THE ANTIACCELERATOR CARDIAC ACTION OF QUININE AND QUINIDINE

Otto Krayer 1

1 Department of Pharmacology, Harvard Medical School, Boston, Mass.

Quinine and quinidine antagonize the cardioaccelerator action of epinephrine in the heart-lung preparation of the dog. The action is similar to that of the veratrum alkaloids, veratramine and jervine, in that it sets in abruptly, is persistent, and is not prevented or abolished by atropine. The potency of quinine is only 1/500 of that of veratramine and 1/10 of that of jervine when studied under identical conditions. The antiaccelerator cardiac action of quinine and quinidine is less selective than that of veratramine and jervine; doses lower than would be required to cause complete inhibition of the positive chronotropic effect of epinephrine cause severe irregularities of rate and rhythm and a marked negative inotropic effect.

Submitted on June 15, 1950







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1950 by the American Society for Pharmacology and Experimental Therapeutics.